Stock 4155 OK BIOTECH CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials OK Biotech Co., Ltd.

Equities

4155

TW0004155007

Medical Equipment, Supplies & Distribution

End-of-day quote Taiwan S.E.
Other stock markets
 03:30:00 29/04/2024 am IST 		5-day change 1st Jan Change
27.55 TWD +6.17% Intraday chart for OK Biotech Co., Ltd. +15.27% +9.76%
19/03 OK Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
12/03 Ok Biotech Co., Ltd. Resolved to Approve cash Dividend Distribution for January 1, 2023 to December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 1,873 2,474 2,524 2,217 2,643 3,656
Enterprise Value (EV) 1 1,965 2,687 2,271 2,173 2,787 3,623
P/E ratio 11.9 x 20.6 x 18.5 x 51.5 x 21.5 x 1,255 x
Yield 9.05% 4.33% 5.19% 4.28% 4.46% 1.2%
Capitalization / Revenue 1.67 x 1.99 x 1.7 x 1.75 x 1.78 x 3.07 x
EV / Revenue 1.75 x 2.16 x 1.53 x 1.72 x 1.88 x 3.04 x
EV / EBITDA 11.7 x 18.2 x 13.3 x 36.4 x 16.8 x 60.1 x
EV / FCF -157 x -162 x 13.5 x -17 x -18.6 x -6.87 x
FCF Yield -0.64% -0.62% 7.43% -5.9% -5.39% -14.5%
Price to Book 1.47 x 2 x 1.46 x 1.3 x 1.49 x 1.53 x
Nbr of stocks (in thousands) 83,091 81,504 1,03,214 1,04,630 1,05,716 1,45,669
Reference price 2 22.55 30.35 24.45 21.19 25.00 25.10
Announcement Date 28/03/19 23/03/20 31/03/21 30/03/22 29/03/23 19/03/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 1,120 1,241 1,484 1,263 1,484 1,192
EBITDA 1 167.4 147.8 171.2 59.72 165.9 60.32
EBIT 1 137.1 111 126.1 8.09 101.8 -12.06
Operating Margin 12.24% 8.94% 8.49% 0.64% 6.86% -1.01%
Earnings before Tax (EBT) 1 201.6 143.4 151.7 46.14 175.6 8.026
Net income 1 161.4 125.8 129.7 43.46 143.5 2.948
Net margin 14.4% 10.13% 8.74% 3.44% 9.67% 0.25%
EPS 2 1.896 1.474 1.319 0.4113 1.162 0.0200
Free Cash Flow 1 -12.53 -16.6 168.8 -128.2 -150.1 -527
FCF margin -1.12% -1.34% 11.37% -10.15% -10.12% -44.21%
FCF Conversion (EBITDA) - - 98.61% - - -
FCF Conversion (Net income) - - 130.14% - - -
Dividend per Share 2 2.042 1.316 1.270 0.9073 1.116 0.3000
Announcement Date 28/03/19 23/03/20 31/03/21 30/03/22 29/03/23 19/03/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 91.8 213 - - 144 -
Net Cash position 1 - - 252 43.6 - 33.4
Leverage (Debt/EBITDA) 0.5484 x 1.443 x - - 0.8677 x -
Free Cash Flow 1 -12.5 -16.6 169 -128 -150 -527
ROE (net income / shareholders' equity) 13% 8.78% 7.98% 1.83% 7.7% -0.08%
ROA (Net income/ Total Assets) 4.59% 3.41% 3.32% 0.19% 2.17% -0.25%
Assets 1 3,517 3,687 3,910 22,996 6,622 -1,198
Book Value Per Share 2 15.30 15.10 16.70 16.30 16.80 16.40
Cash Flow per Share 2 2.260 3.900 5.490 5.730 5.440 2.220
Capex 1 27.5 63.4 79.8 79.1 287 430
Capex / Sales 2.46% 5.11% 5.38% 6.26% 19.33% 36.05%
Announcement Date 28/03/19 23/03/20 31/03/21 30/03/22 29/03/23 19/03/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Medical Equipment

1st Jan change Capi.
OK BIOTECH CO., LTD. Stock OK Biotech Co., Ltd.
+9.76% 123M
SHOCKWAVE MEDICAL, INC. Stock Shockwave Medical, Inc.
+72.92% 12.36B
PENUMBRA, INC. Stock Penumbra, Inc.
-19.68% 7.83B
MASIMO CORPORATION Stock Masimo Corporation
+16.20% 7.21B
GETINGE AB Stock Getinge AB
+6.78% 5.97B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. Stock Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
+7.49% 5.14B
APT MEDICAL INC. Stock APT Medical Inc.
+23.97% 4.43B
ASAHI INTECC CO., LTD. Stock Asahi Intecc Co., Ltd.
-18.93% 3.9B
INARI MEDICAL, INC. Stock Inari Medical, Inc.
-41.54% 2.2B
SKAN GROUP AG Stock SKAN Group AG
+1.24% 2.02B
Medical Equipment
  1. Stock Market
  2. Equities
  3. 4155 Stock
  4. Financials OK Biotech Co., Ltd.